183 related articles for article (PubMed ID: 10547029)
21. Modulation of biomarkers by chemopreventive agents in smoke-exposed rats.
Izzotti A; Balansky RM; Dagostini F; Bennicelli C; Myers SR; Grubbs CJ; Lubet RA; Kelloff GJ; De Flora S
Cancer Res; 2001 Mar; 61(6):2472-9. PubMed ID: 11289117
[TBL] [Abstract][Full Text] [Related]
22. Cancer risk assessment for crotonaldehyde and 2-hexenal: an approach.
Eder E; Schuler D; Budiawan
IARC Sci Publ; 1999; (150):219-32. PubMed ID: 10626223
[TBL] [Abstract][Full Text] [Related]
23. [Molecular biology of tobacco smoke associated neoplasia].
Zojer N; Fritsche R; Fiegl M; Schulte-Hermann R; Mannhalter C; Huber H
Wien Klin Wochenschr; 1996; 108(18):574-81. PubMed ID: 9012141
[TBL] [Abstract][Full Text] [Related]
24. Body mass index modulates aromatic DNA adduct levels and their persistence in smokers.
Godschalk RW; Feldker DE; Borm PJ; Wouters EF; van Schooten FJ
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):790-3. PubMed ID: 12163336
[TBL] [Abstract][Full Text] [Related]
25. Tobacco smoke-associated N7-alkylguanine in DNA of larynx tissue and leucocytes.
Szyfter K; Hemminki K; Szyfter W; Szmeja Z; Banaszewski J; Pabiszczak M
Carcinogenesis; 1996 Mar; 17(3):501-6. PubMed ID: 8631136
[TBL] [Abstract][Full Text] [Related]
26. Oxidative DNA base modifications and polycyclic aromatic hydrocarbon DNA adducts in squamous cell carcinoma of larynx.
Jałoszyński P; Jaruga P; Oliński R; Biczysko W; Szyfter W; Nagy E; Möller L; Szyfter K
Free Radic Res; 2003 Mar; 37(3):231-40. PubMed ID: 12688418
[TBL] [Abstract][Full Text] [Related]
27. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
[TBL] [Abstract][Full Text] [Related]
28. Human biomonitoring: state of the art.
Angerer J; Ewers U; Wilhelm M
Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
[TBL] [Abstract][Full Text] [Related]
29. DNA adducts of aromatic amines present in tobacco smoke.
Marques MM; Beland FA
IARC Sci Publ; 1994; (125):453-6. PubMed ID: 7806338
[No Abstract] [Full Text] [Related]
30. Applicability of induced sputum for molecular dosimetry of exposure to inhalatory carcinogens: 32P-postlabeling of lipophilic DNA adducts in smokers and nonsmokers.
Besaratinia A; Maas LM; Van Breda SG; Curfs DM; Kleinjans JC; Wouters EF; Van Schooten FJ
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):367-72. PubMed ID: 10794480
[TBL] [Abstract][Full Text] [Related]
31. [Comparison of DNA adducts between oral, pharyngeal and larynx cancer].
Pabiszczak M; Banaszewski J; Szmeja Z; Szyfter K; Szyfter W
Otolaryngol Pol; 2001; 55(5):551-4. PubMed ID: 11868331
[TBL] [Abstract][Full Text] [Related]
32. Exocyclic malondialdehyde and aromatic DNA adducts in larynx tissues.
Munnia A; Amasio ME; Peluso M
Free Radic Biol Med; 2004 Sep; 37(6):850-8. PubMed ID: 15304257
[TBL] [Abstract][Full Text] [Related]
33. Contribution of alcohol and tobacco use in gastrointestinal cancer development.
Seitz HK; Cho CH
Methods Mol Biol; 2009; 472():217-41. PubMed ID: 19107435
[TBL] [Abstract][Full Text] [Related]
34. Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens.
Bartsch H; Malaveille C; Friesen M; Kadlubar FF; Vineis P
Eur J Cancer; 1993; 29A(8):1199-207. PubMed ID: 8518034
[TBL] [Abstract][Full Text] [Related]
35. Analysis of aromatic DNA adducts in laryngeal biopsies.
Banaszewski J; Szmeja Z; Szyfter W; Szyfter K; Baranczewski P; Möller L
Eur Arch Otorhinolaryngol; 2000; 257(3):149-53. PubMed ID: 10839488
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the DNA damaging potential of cannabis cigarette smoke by the determination of acetaldehyde derived N2-ethyl-2'-deoxyguanosine adducts.
Singh R; Sandhu J; Kaur B; Juren T; Steward WP; Segerbäck D; Farmer PB
Chem Res Toxicol; 2009 Jun; 22(6):1181-8. PubMed ID: 19449825
[TBL] [Abstract][Full Text] [Related]
37. Nonsmoking-related arylamine exposure and bladder cancer risk.
Skipper PL; Tannenbaum SR; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):503-7. PubMed ID: 12814994
[TBL] [Abstract][Full Text] [Related]
38. GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: a study in rural Thailand.
Pisani P; Srivatanakul P; Randerson-Moor J; Vipasrinimit S; Lalitwongsa S; Unpunyo P; Bashir S; Bishop DT
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):667-74. PubMed ID: 16614107
[TBL] [Abstract][Full Text] [Related]
39. [Sex-dependence of larynx susceptibility to tobacco smoke carcinogens. The role of androgen hormones].
Szyfter K; Kruk-Zagajewska A; Szmeja Z; Kozak W; Szyfter W; Kujawski M; Banaszewski J; Wójtowicz J
Otolaryngol Pol; 1998; 52(2):153-8. PubMed ID: 9673113
[TBL] [Abstract][Full Text] [Related]
40. Genotoxicity of tobacco smoke-derived aromatic amines and bladder cancer: current state of knowledge and future research directions.
Besaratinia A; Tommasi S
FASEB J; 2013 Jun; 27(6):2090-100. PubMed ID: 23449930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
